Dupilumab Approved for Allergic Fungal Rhinosinusitis

The FDA has approved dupilumab to treat allergic fungal rhinosinusitis in adults and children ages 6 years and older.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/dupilumab-approved-allergic-fungal-rhinosinusitis-2026a10005zi?src=rss

Author :

Publish date : 2026-02-25 17:17:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Dupilumab Approved for Allergic Fungal Rhinosinusitis

Age, HIV, and Metabolic Syndrome Together Tied to Cognitive Impairment Risk

Sperm swim more quickly in summer, study finds

Related Posts

Beware of Radiation Doses Among Heart Scanners, Study Says

Cannabis and Psychosis; Legalize Psilocybin? Addiction After Dopamine Agonists

New Guidance Released on ‘Whether and When’ to Stop Psychotropic Meds

RFK Jr.’s Anti-Vaccine Stance Infiltrated FDA. Trump Is Reining It In.

FDA Grants Full Approval to Encorafenib in Metastatic CRC

Sperm swim more quickly in summer, study finds

Beware of Radiation Doses Among Heart Scanners, Study Says

Cannabis and Psychosis; Legalize Psilocybin? Addiction After Dopamine Agonists

RFK Jr.’s Anti-Vaccine Stance Infiltrated FDA. Trump Is Reining It In.

FDA Grants Full Approval to Encorafenib in Metastatic CRC

Sperm swim more quickly in summer, study finds

Dupilumab Approved for Allergic Fungal Rhinosinusitis

Age, HIV, and Metabolic Syndrome Together Tied to Cognitive Impairment Risk

Single-Dose Dolutegravir Safe in Kids With HIV Receiving Preventive TB Treatment

Categories

Archives